A detailed history of Td Private Client Wealth LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Td Private Client Wealth LLC holds 457 shares of TECH stock, worth $34,965. This represents 0.0% of its overall portfolio holdings.

Number of Shares
457
Holding current value
$34,965
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $28,388 - $38,456
457 New
457 $32.7 Million
Q4 2023

Aug 16, 2024

BUY
$52.83 - $78.22 $20,498 - $30,349
388 Added 485.0%
468 $36.1 Million
Q3 2023

Aug 16, 2024

SELL
$67.52 - $89.42 $2,228 - $2,950
-33 Reduced 29.2%
80 $5.45 Million
Q2 2023

Aug 16, 2024

BUY
$73.76 - $85.98 $4,056 - $4,728
55 Added 94.83%
113 $9.22 Million
Q1 2023

Aug 16, 2024

SELL
$71.62 - $86.62 $429 - $519
-6 Reduced 9.38%
58 $4.3 Million
Q4 2022

Aug 16, 2024

BUY
$80.67 - $352.29 $1,371 - $5,988
17 Added 36.17%
64 $5.3 Million
Q3 2022

Aug 16, 2024

BUY
$282.54 - $391.85 $10,453 - $14,498
37 Added 370.0%
47 $13.3 Million
Q2 2022

Aug 16, 2024

SELL
$322.67 - $449.65 $7,098 - $9,892
-22 Reduced 68.75%
10 $3.47 Million
Q1 2022

Aug 16, 2024

SELL
$353.85 - $487.79 $153,924 - $212,188
-435 Reduced 93.15%
32 $13.9 Million
Q4 2021

Aug 16, 2024

BUY
$456.15 - $525.06 $2,280 - $2,625
5 Added 1.08%
467 $242 Million
Q3 2021

Aug 16, 2024

BUY
$444.87 - $538.88 $2,224 - $2,694
5 Added 1.09%
462 $224 Million
Q1 2021

Aug 16, 2024

SELL
$314.62 - $411.0 $9,123 - $11,919
-29 Reduced 5.95%
458 $175 Million
Q4 2020

Aug 16, 2024

SELL
$246.9 - $321.87 $1,728 - $2,253
-7 Reduced 1.42%
487 $155 Million
Q3 2020

Aug 16, 2024

BUY
$232.22 - $282.96 $111,465 - $135,820
480 Added 3428.57%
494 $122 Million
Q4 2019

Aug 16, 2024

SELL
$189.68 - $222.09 $84,028 - $98,385
-443 Reduced 96.94%
14 $3.07 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $3B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.